New tool aims to help people decide on Multi-Cancer blood tests
NCT ID NCT06870916
First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 33 times
Summary
This study aims to develop an educational aid to help people make informed decisions about multi-cancer early detection (MCED) blood tests. Researchers will hold focus groups with 150 participants to discuss knowledge, preferences, and concerns about these tests. The goal is to create a tool that clearly explains the risks and benefits of MCED screening.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTI-CANCER EARLY DETECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could create a tool that helps people better understand and decide about multi-cancer early detection blood tests.
What could go wrong
This is a small, suspended focus group study to develop an educational aid, not a test of the screening itself. It may not lead to widespread use or improved health outcomes.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.